Hepatotoxicity in patients (pts) with KRASG12C-mutated non-small cell lung cancer (NSCLC) treated with sotorasib after prior immunotherapy (IO)

被引：0
|
作者：
Ernst, S. M. [1 ]
de Bruijn, P. [2 ]
van der Horst, T. E. [1 ]
Paats, M. S. [1 ]
Aerts, J. G. [1 ]
Mathijssen, R. H. [2 ]
Koolen, S. L. [2 ]
Dingemans, A-M. C. [1 ]
机构：
[1] Erasmus MC Canc Inst, Dept Resp Med, Rotterdam, Netherlands
[2] Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2430
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1398P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRASG12C-Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review
    Luo, Jia
    Florez, Narjust
    Donnelly, Anjali
    Lou, Yanyan
    Lu, Kevin
    Ma, Patrick C.
    Spira, Alexander I.
    Ryan, Debra
    Husain, Hatim
    JCO PRECISION ONCOLOGY, 2024, 8
  • [2] Mechanisms of resistance to KRASG12C inhibitors in KRASG12C-mutated non-small cell lung cancer
    Chour, Ali
    Toffart, Anne-Claire
    Berton, Elodie
    Duruisseaux, Michael
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [3] PREDICTIVE ANALYSIS COMPARING ECONOMIC AND CLINICAL CONSEQUENCES OF TREATMENT-RELATED HEPATOTOXICITY IN KRASG12C-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (ANSCLC) PATIENTS TREATED POST-IMMUNOTHERAPY (IO)
    Keeping, S.
    Zhang, W.
    Berardi, A.
    Bouwmeester, W.
    Qian, C.
    Gao, S.
    Vaysman, A.
    Laurie, M.
    Korytowsky, B.
    VALUE IN HEALTH, 2024, 27 (06) : S150 - S150
  • [4] Hepatotoxicity in patients with non-small cell lung cancer treated with sotorasib after prior immunotherapy: a comprehensive clinical and pharmacokinetic analysis
    Ernst, Sophie M.
    Hofman, Maaike M.
    van der Horst, Tessa E.
    Paats, Marthe S.
    Aerts, Joachim G. J. V.
    Heijboer, Frank W. J.
    Dumoulin, Daphne W.
    Cornelissen, Robin
    von der Thusen, Jan H.
    de Bruijn, Peter
    Hoop, Esther Oomen-de
    Mathijssen, Ron H. J.
    Koolen, Stijn L. W.
    Dingemans, Anne -Marie C.
    EBIOMEDICINE, 2024, 102
  • [5] Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRASG12C-Mutated NSCLC Treated With Sotorasib
    Ernst, Sophie M.
    van Marion, Ronald
    Atmodimedjo, Peggy N.
    de Jonge, Evert
    Mathijssen, Ron H. J.
    Paats, Marthe S.
    de Bruijn, Peter
    Koolen, Stijn L.
    von der Thuesen, Jan H.
    Aerts, Joachim G. J. V.
    Schaik, Ron H. N. van
    Dubbink, Hendrikus J.
    Dingemans, Anne-Marie C.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : 995 - 1006
  • [6] Coexisting Genomic Alterations in Risk Stratification of KRASG12C-Mutated Non-Small Cell Lung Cancer
    Heng, Sarina Z. W.
    Hoo, Regina
    Tan, Daniel S. W.
    CANCER DISCOVERY, 2023, 13 (07) : 1513 - 1515
  • [7] Sotorasib: a KRASG12C inhibitor for non-small cell lung cancer
    Ganguly, Arghya
    Yoo, Euna
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (06) : 536 - 537
  • [8] Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRASG12C-Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review (vol 8, e2300644, 2024)
    Luo, Jia
    JCO PRECISION ONCOLOGY, 2024, 8
  • [9] Exploratory biomarker analyses from a phase 2 trial evaluating sotorasib in patients with pre-treated KRASG12C-mutated non-small cell lung cancer (CodeBreaK 100)
    Schuler, M.
    Italiano, A.
    Li, B.
    Dy, G.
    Skoulidis, F.
    Kato, T.
    Anderson, A.
    Ang, A.
    Ngarmchamnanrith, G.
    Addeo, A.
    Wolf, J.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S38 - S38
  • [10] Tackling KRASG12C-mutated non-small-cell lung cancer: iteration and exploration
    Luo, Jia
    Villaruz, Liza C.
    LANCET RESPIRATORY MEDICINE, 2024, 12 (08): : 576 - 577
12345